Everyone knows that the new chimeric antigen receptor T cell immunotherapy is developed by a biological research laboratory, and has no connection with Xu Yun, an academician of the Institute of Quantum Information Technology of the Academy of Sciences, but it was in this situation that Xu Yun was found to appear in Feng Wanqin's recorded video.

This shows that Xu Yun is involved in a new chimeric antigen receptor T cell immunotherapy.

If this is the case, then it is not surprising that this treatment can cure cancer.

After all, many previous examples have proved that it is impossible for any project with Xu Yun to fail.

If everyone eliminated their doubts because of Feng Wanqin's video, then seeing Xu Yun completely fell into madness.

Be sure that cancer has really been conquered.

There is no guarantee that you will not get cancer, especially in recent years, cancer has been getting younger, and the number of young people suffering from cancer is increasing.

Although everyone usually doesn't care, they are still worried.

I am afraid that one day I or my family will be diagnosed with cancer.

At that time, I am afraid that the whole life will be completely darkened, and whether I can get out of it is a question.

But now it's good.

There is a real cure for cancer.

It even only costs tens of thousands of dollars.

It's exciting to think about.

Soon after the news spread, several more topics appeared outside the hot search, and the number of netizens who participated in the discussion was also terrifying.

And this time it's almost all supportive voices.

"What am I talking about, the biological research laboratory has been precipitating for several years and finally announced the results, obviously deliberately saving a king bomb, how can it be possible to do things that damage your image."

"You can always believe in Deepin Technology and Xu Shen!"

"Damn, this is too awesome, don't you have to worry about cancer in the future?"

"It was so tragic that she got pancreatic cancer at the age of eighteen, but fortunately she caught up with the most suitable time."

"I can basically confirm that the one in the video is definitely Academician Xu, it seems that he must know about this technology."

"Who said that this technology is not effective in treatment, but now I ask if it hurts to be beaten in the face, and even such a serious pancreatic cancer can be cured, let alone other ordinary cancers."

"Now I don't have to worry about getting cancer anymore, I can treat it anyway."

"In any case, this is a project of Deepin Technology, and it is normal for Academician Xu to appear."

"Do you think there is a possibility that Academician Xu is also involved in the research of this cancer therapy technology, after all, Academician Xu likes to challenge difficulties the most."

……

"This saves us from doing it." At the same time, in the biological research laboratory, Xu Yun checked the situation on the Internet, turned his head and said to Ding Wei, Zhou Lihua and others beside him, the corners of his mouth were slightly raised, and a smile was raised.

In fact, they don't care about the direction of the Internet at all.

The new chimeric antigen receptor T-cell immunotherapy serves cancer patients, not netizens.

Whether netizens believe the effect or not, cancer patients who get the news will definitely not give up.

Not to mention whether it can achieve the advertised treatment effect, even if there is even the slightest hope, I will try it.

Because for them there is simply no choice.

As long as enough cancer patients are cured, no one will question its effectiveness at that time.

But I didn't expect Feng Wanqin to use a video to make public opinion change in advance.

While this is a good thing, it can also lead to a spike in pressure in their labs.

I don't know how many cancer patients will flock to the city.

He also noticed a lot of discussion about his role in the project.

In short, there is everything to say.

He didn't take it to heart either.

Anyway, it's not the first time he's engaged in crossover, and even if the outside world knows that it was his successful optimization of chimeric antigen receptor T-cell immunotherapy, it is estimated that there will not be much response.

"It's smart that this kid can come up with such a solution." Zhou Lihua opened her mouth and agreed.

His expression revealed his appreciation for Feng Wanqin.

After all, although Feng Wanqin participated in human trials in the laboratory, she didn't need to do anything in this matter.

The fact that the other party can take the initiative to post this video shows that she is very grateful.

Not the kind of villain who doesn't have gratitude.

"Everyone knows the situation now, and you guys will be busy next."

Xu Yun still said to the few people in front of him with a smile, which can be regarded as letting everyone prepare in advance.

But Ding Wei: They weren't very worried.

He immediately spoke:

"Don't worry, our laboratory will definitely be fine, relying on the assembly line to transform the mode of expanding cells is very efficient."

What Ding Wei said is indeed true.

If the internationally used cell modification and expansion methods are changed, it may take 30 days for each patient to complete the injection, and you can imagine how inefficient it is.

Not to mention that the number of cancer patients in Jingzhou City is increasing rapidly, even those people can't solve it.

There will definitely be problems then.

"As long as we stick to this time, when other cities have the conditions for treatment, the pressure will be greatly reduced to a normal level."

Xu Yun nodded in response and said no more, he still believed in the ability of everyone in the laboratory.

In addition, at present, the new chimeric antigen receptor T-cell immunotherapy has been officially approved and launched, and there are not many things that need him to participate in the follow-up.

In this case, he definitely can't stay in the lab anymore, so he naturally has to do something new.

Although Hou Shengchang, the president of the Academy of Sciences, gave him a few years to learn new knowledge and grow, it didn't take him that long with his talent, and the new chimeric antigen receptor T-cell immunotherapy that is currently online is the best proof that he has mastered a new field.

Of course, whether to return to the Institute of Quantum Information Technology to continue to study Zu Chongzhi No. 3, improve the computing power of the quantum computer cloud platform, or to learn other new field knowledge, he has not yet made a decision, and he will wait until the end of the mission to get the reward.

Next, as Xu Yun predicted, with the spread of the popularity of new chimeric antigen receptor T-cell immunotherapy, more and more cancer patients can't sit still.

Especially seeing that even Feng Wanqin, who had pancreatic cancer, could be cured, she couldn't wait to go to Jingzhou City for treatment immediately.

Some patients regret that they should not have been transferred in the first place.

The First Hospital of Jingzhou City may be the best hospital in Jingzhou City, but it cannot be compared with the Imperial Capital of the Demon Capital.

Previously, the biological research laboratory had not started human trials, so transferring to a hospital for better treatment was the best option.

It can only be said that no one thought that the almost unknown Jingzhou Biological Research Laboratory would suddenly become so beneficial and directly solve the cancer problem that has plagued mankind for many years.

It is conceivable how many cancer patients will appear at the high-speed rail stations and airports in Jingzhou in the next period of time.

However, it is obviously unrealistic to want to treat cancer patients across the country with just one Jingzhou biological research laboratory.

In this regard, in big cities such as Yangcheng and Shenshi, the imperial capital, hospitals inside also began to shout.

He said that he will soon be able to treat a new chimeric antigen receptor T cell immunotherapy.

Although the results were not very satisfactory, they were still successful in persuading many cancer patients.

It gives others a hope.

The main thing is that there is no way to do it, and the number of cancer patients that Gyeongju First Hospital can accept is limited.

Once out of range, no more patients will be accepted.

In this case, even if you go to Jingzhou City, there is no way to get treatment with the new technology.

After determining this situation, many people can only choose to go home.

After all, in other hospitals, you can still carry out routine treatment control first, and wait for more hospitals to open up new technologies, if you stay in Jingzhou City and can't stay in the hospital, the condition will only accelerate the deterioration.

Maybe if you can't wait for treatment, your body won't be able to hold it up first.

Just when the new chimeric antigen receptor T-cell immunotherapy was officially approved and launched, Paina, the representative of Ruihui Biologics, who had been waiting for several days at the Imperial Park Hotel, finally lost her patience completely, and had no choice but to take the assistant back to the company's headquarters by plane.

Since Liu Xuezhi suddenly changed his attitude and was very determined to cancel all anti-cancer drug cooperation with Ruihui, she fell into panic and worry.

Some even regret what they did before, and should not trust their own judgment too much.

In order to make up for the trouble she caused, she has been trying to contact Liu Xuezhi and others for the next few days.

But the result was that Liu Xuezhi was no longer in the imperial capital, and no one was even willing to meet with her again to negotiate.

At first, she still had some hopes, and even offered generous conditions to take the initiative to reduce the price of centralized procurement of anti-cancer drugs.

Still, things haven't changed.

It made her desperate.

In addition, she also made people pay attention to the trends of other well-known pharmaceutical companies, and found that Liu Xuezhi had not contacted them, which made her very puzzled.

Anti-cancer drugs are obviously something that must be lacking, and such a large market demand can be imagined.

Even if you don't cooperate with them Ruihui, you will have to find someone else.

As a result, the other party was stunned and did not make any action.

For this reason, Payina, who was tortured a lot, had to choose to return to the company's headquarters first to report to the boss.

In fact, in the past few days, she has also received an email from her boss Ai Bole, asking how her negotiations are going, and in the reply email, she can only find an excuse to prevaricate.

Of course, she also knew in her heart that this was only temporary, and since it was certain that the matter of negotiation could not be reversed, she could only report to the higher authorities truthfully.

……

On the way back, Paina was in a very low mood, and the negative aura that almost overflowed was like the tough-wristed character in the past.

In the face of the boss in this state, the assistant was also very knowledgeable and did not dare to disturb the whole process.

In this way, when the plane landed smoothly in the twist, Payina went straight to the company without going home to rest.

As the current CEO of Pfizer, Abola has great ambitions, and he hopes that the company can completely occupy the global anti-cancer drug market.

And sending Payina to the imperial capital to negotiate is a very important link.

Naturally, he also attached great importance to the outcome of the negotiations.

Knowing that Payina had returned to the company, he simply pushed down the meeting he was waiting to attend and asked Payina to report to his office.

Ebolle opened the door to his office and found Payina sitting on the couch next to her.

However, after seeing the other party, he couldn't help frowning.

He had the impression that he was a capable general, always full of confidence, as if nothing could hold her back, so he chose to send Payina on this mission.

But now he can't see that confidence in Payina, which is definitely not a good thing.

Although he didn't know what was going on, he always had a feeling that there wouldn't be any good news.

Holding back the uneasiness in his heart for the time being, he took the initiative to speak: "Did this journey go well?" ”

Because she was sitting alone in her boss's office, Paina couldn't help but immerse herself in this trip to the imperial capital, and she had never failed so thoroughly since she started working.

It wasn't until he heard a familiar voice that he quickly came into a trance, and quickly stood up to say hello.

"Boss."

"Let's sit down first." Ebolle took care of Payina and sat down.

At this time, the secretary in the office brought two glasses of red wine and put them on the table, and then consciously left to let the boss and Payina talk alone.

After sitting down across from Payina, Ebolle raised her glass and shook it as she asked about Payina.

"How did you go to the imperial capital to negotiate with the other party this time, and are they willing to accept our price?"

Seeing that the topic finally got down to business, Payina knew that she couldn't continue to hide it, so she had to report truthfully what happened in the imperial capital.

"Boss, I failed."

As Payina's words fell, Rao is Ai Bole had already faintly felt that his face was still inevitably pulled.

I thought that Payina, the most capable person in the dispatch company, should be in charge, and it should be a matter of course, but he got such an unacceptable result.

However, he also knew that now was not the time for an attack, and Paina was also an ordinary employee of the company.

So he took a deep breath, put the wine glass in his hand back on the table, and asked with a frown.

"Don't they accept our price?"

In order to win this purchase order, the price he gave was not high compared to other regions.

After all, Rolagoni has just been launched as a new drug, and he must not let the price drop too quickly.

Of course, Paina would not tell herself that the price quoted was higher than the price given by Ebol, which would be equivalent to putting all the blame on herself.

At that time, he will definitely be punished by the company, and he may not be able to continue to stay in Ruihui Biotech.

After thinking for a moment in her mind, she replied, "It shouldn't be a matter of price, the other party took the initiative to give up the purchase of Rolagni." ”

"Gave up?"

"Could it be that they have a replacement?"

Ai Bole did not doubt Paina's answer, but thought that it might be cut off by other companies.

But Paina shook her head: "I haven't found any contact with other pharmaceutical companies during this time. ”

After listening to Payina's answer, Ai Bole couldn't help but fall into deep thought.

Obviously, the other party has the desire to purchase new anti-cancer, so he specially sent Paina to negotiate, and it stands to reason that even if the price is not suitable, he can continue to negotiate and confirm, after all, this kind of price cooperation cannot be finalized in a short time.

But the other party directly chose to give up the procurement, and its approach is indeed a little unimaginable.

I don't know what I want to do.

And just as Ebolle was pondering about this, Paina, who was next to her, had no intention of stopping.

In the next second, he said something shockingly again, saying something very important.

"There is another thing that the boss, in addition to giving up the purchase of our new anti-cancer drug Rolagnib, the cooperation of other anti-cancer drugs has also decided to stop altogether."

"What did you say?"

If Ai Bole could still maintain his composure just now, then after hearing Payina's words, he completely lost control of his emotions and stood up suddenly.

Disbelief was written all over the face.

"Are they crazy, they want to stop all cooperation, who gave them the confidence?"

He is well aware of the importance of anti-cancer drugs, especially in areas where their anti-cancer drugs have limited effectiveness.

Rolagnib is expensive as a new drug, and it is understandable that he chose to abandon procurement, and there are other anti-cancer drugs to meet the demand anyway.

But if the cooperation is completely stopped now, there will soon be a huge gap in the other party's anti-cancer drugs.

"When I was in the imperial capital, I also felt very puzzled about this matter, but unfortunately I didn't find the answer." Paina's mood had calmed down at the moment, and she took over the conversation and expressed her opinion.

As for Ai Bole, he insisted on his own judgment and quickly said in a deep voice: "Anti-cancer drugs are indispensable for them, I think they must have secretly reached a cooperation with other pharmaceutical companies, and they must find each other as soon as possible." ”

Payina asked tentatively, "Could it be their own pharmaceutical company?" ”

"It's absolutely impossible." Ebola shook his head and dismissed Paina's speculation.

And then don't forget to explain.

"With their research on anti-cancer drugs, the therapeutic effect is very limited and not accepted by patients at all, so they will definitely not only use their own anti-cancer drugs."

"I'll take care of this and find out the other party's as soon as possible." Payina was the first to take on the task.

Although Ai Bole was dissatisfied with Payina's performance this time, the other party's sudden cessation of all cooperation was indeed strange, and the blame could not be placed on Payina.

After a little hesitation, he agreed to Payina's request.

However, just as Payina got her new assignment and was about to leave, there was a sudden knock on the door outside.

Ai Bole didn't think much about it, and directly opened his mouth to let the other party in.

"Come in."

The next second, I saw a young man with blond hair in a formal suit enter, seemingly holding a newspaper in his hand.

After seeing Payina sitting on the sofa, she didn't forget to simply nod her head.

Judging from the performance of Ai Bole and Payina, it is obvious that the other party also belongs to a certain executive in the company.

"Boss's latest news, Deepin Technology has just released a new research result." The young man walked up to Ai Bole and immediately opened his mouth to report the incident.

Although Ruihui belongs to the pharmaceutical industry and has little connection with technology companies, Aibole is aware of Deepin Technology.

It should be said that there is no company that does not know about Deepin Technology.

But what puzzled him was that it was normal to publish new research results with the influence of deep technology in the world, and it was worth the company's executives to come and tell him, not to mention that this matter didn't seem to have anything to do with their Ruihui.

"Is it unusual for Deepin Technology to release a research result?"

The thought stayed here, and he immediately responded with some accusations.

After all, he was angry about what Paina had reported.

The young man obviously understood what his boss had misunderstood, so he hurriedly opened his mouth to explain.

"It's such a boss, and the latest research results released by Deepin Technology have a lot to do with our pharmaceutical industry."

As he spoke, he did not forget to hand over the newspaper in his hand.

Although Ai Bole was still a little puzzled when he heard this, he still took the newspaper and lowered his gaze to check the contents on it.

And it's okay not to read it, when the content of the newspaper catches his eye, his face instantly pulls down.

Because the newspaper is full of reports on the new chimeric antigen receptor T cell immunotherapy in the biological research laboratory of Deepin Technology.

And it also occupies a very large space.

He can naturally have his own analysis and judgment in this position, and almost instantly he connects the two things.

It is no wonder that the medical bureau suddenly stopped all cooperation, and it turned out that it was putting its hopes on the new research results of deep technology, so everything can be explained.

However, this can't be blamed for not thinking about it before, after all, he only knew that the other party's pharmaceutical company was limited in strength and could not produce anti-cancer drugs with sufficient effects for the time being, so he didn't take it to heart and thought that the other party had found other overseas companies to cooperate.

As a result, it was deep technology that did not succeed in breaking the game, and directly abandoned the traditional drug selection chimeric antigen receptor T-cell immunotherapy.

A large number of thoughts quickly appeared in his mind under his gloomy face, and it took about a few seconds before he raised his eyes and said to Payina: "The task just now is canceled, I already know the reason why they gave up the purchase." ”

"Cancel the mission?"

Paina was a little stunned when she heard this, and was about to ask, but found that Ai Bole handed over the newspaper in his hand.

She took the newspaper with doubts, and after reading the contents, she couldn't help but fall silent.

During this time, she was always confused by this question, and no matter how hard she tried, she couldn't get the answer, who would have thought that it was actually related to Deepin Technology.

But it has to be said that this result is more unfavorable to them than cooperating with other overseas pharmaceutical companies.

After all, if patients choose to be treated with a new chimeric antigen receptor T cell immunotherapy with deep technology, then who will buy their anti-cancer drugs?

What's more, as a new drug, rolaginib has just been launched, and the huge amount of money invested in research and development has not been recovered.

At this time, Ai Bole finally couldn't hold his breath, and looked at the young man in front of him and asked, "How much do you know about this new research result of Deepin Technology, and can it really cure cancer as reported?" ”

"Judging from the information released by the other party, this technology is indeed far superior to the effect of our anti-cancer drugs." When asked by his boss, the young man answered without hesitation.

And this sentence also made Ai Bole's mood more solemn, I didn't expect this kind of thing to happen when the new drug was just launched.

If it is not handled properly, I am afraid that the global anti-cancer drug market will be lost.

His thoughts quickly seemed to have made a decision, and he immediately instructed his subordinates in front of him: "Contact other well-known pharmaceutical companies, we must take action." ”

……

(End of chapter)